Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTriSalus Life Sciences Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.16 | -$0.15 | -$0.16 |
| Q2 2026 | 1 | -$0.11 | -$0.10 | -$0.10 |
| Q3 2026 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q4 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2027 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2027 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q3 2027 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q4 2027 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q1 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2028 | 0 | $0.00 | $0.00 | $0.00 |
TriSalus Life Sciences Inc Earnings Date And Information
TriSalus Life Sciences Inc last posted its earnings results on Thursday, March 5th, 2026. The company reported $-0.12 earnings per share for the quarter, topping analysts' consensus estimates of $-0.13 by $0.01. The company had revenue of 13.21 M for the quarter and had revenue of 45.15 M for the year. TriSalus Life Sciences Inc has generated $-2 earnings per share over the last year ($-1.84 diluted earnings per share) and currently has a price-to-earnings ratio of -5.44. TriSalus Life Sciences Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
TriSalus Life Sciences Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/05/2026 | Q4 2025 | -$0.13 | -$0.21 | -0.08 | $12.82 M | $13.21 M |
| 11/13/2025 | Q3 2025 | -$0.17 | -$0.96 | -0.79 | $11.76 M | $11.57 M |
| 08/12/2025 | Q2 2025 | -$0.22 | -$0.27 | -0.05 | $10.70 M | $11.21 M |
| 05/15/2025 | Q1 2025 | -$0.20 | -$0.39 | -0.19 | $9.04 M | $9.17 M |
| 04/15/2025 | Q4 2024 | N/A | -$0.41 | N/A | $8.12 M | $8.26 M |
| 11/14/2024 | Q3 2024 | -$0.36 | -$0.12 | 0.24 | $7.38 M | $7.35 M |
| 08/14/2024 | Q2 2024 | -$0.49 | -$0.21 | 0.28 | $6.88 M | $7.36 M |
| 03/30/2024 | Q1 2024 | N/A | -$0.60 | N/A | $6.17 M | $6.46 M |
| 12/30/2023 | Q4 2023 | N/A | -$1.34 | N/A | N/A | $5.72 M |
| 09/29/2023 | Q3 2023 | N/A | -$0.05 | N/A | N/A | $5.19 M |
| 06/29/2023 | Q2 2023 | N/A | -$0.53 | N/A | N/A | $4.61 M |
| 03/30/2023 | Q1 2023 | N/A | -$0.31 | N/A | N/A | $2.98 M |
| 12/30/2022 | Q4 2022 | N/A | -$0.76 | N/A | N/A | $3.23 M |
| 11/10/2022 | Q3 2022 | N/A | -$0.26 | N/A | N/A | $3.92 M |
| 08/10/2022 | Q2 2022 | N/A | $0.08 | N/A | N/A | $2.88 M |
| 05/11/2022 | Q1 2022 | N/A | -$0.25 | N/A | N/A | $2.37 M |
| 03/02/2022 | Q4 2021 | N/A | $0.09 | N/A | N/A | $2.57 M |
| 12/13/2021 | Q3 2021 | N/A | $0.06 | N/A | N/A | $0 |
| 08/16/2021 | Q2 2021 | N/A | $0.01 | N/A | N/A | $0 |
| 06/28/2021 | Q1 2021 | N/A | -$0.01 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TriSalus Life Sciences Inc Earnings: FAQ's
In the previous quarter, TriSalus Life Sciences Inc (:TLSI) reported $-0.12 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.13 by $0.01.
The conference call for TriSalus Life Sciences Inc's latest earnings report can be listened to online.
The conference call transcript for TriSalus Life Sciences Inc's latest earnings report can be read online.
TriSalus Life Sciences Inc (:TLSI) has a recorded annual revenue of $45.15 M.
TriSalus Life Sciences Inc (:TLSI) has a recorded net income of $-39,227,000.TriSalus Life Sciences Inc has generated $-1.84 earnings per share over the last four quarters.
TriSalus Life Sciences Inc (:TLSI) has a price-to-earnings ratio of -5.44 and price/earnings-to-growth ratio is 0.08.